JKS Document Store
 Store FrontAccountSearchProduct ListBasket Contents Checkout 
Search For The Following Word(s):
Sign In

Medicinal Products Lifecycle
Medical Devices
Japan Monitor (ISSN 1550-3429)
Information Meetings
Legislation and Agreements
All in Japan (ISSN 1550-3402)
E-health Japan (ISSN 1550-3410)
EU Pharma & Medical Devices
Free documents

All in Japan: Triptans (Enterprise-wide Use License)

All in Japan: Triptans (Enterprise-wide Use License)Quantity in Basket:none
Code: AJ_T_002

ISSN 1550-3402 ((Enterprise-wide Use License: This document is identical to the Single User License document (AJ_T_001), however by purchasing the Enterprise-wide Use License here you would be granted a right to distribute the document within your organization or to make the document accessible by more than one user within your organization.) 16-page document. <<>> Preamble: The reports from the "All in Japan" series provide overview and concise up-to-date description of each product from a specific product or therapeutic category approved in Japan. All in Japan: Triptans report is a long awaited regulatory compendium on the top selling drug class in Japan. <<>> Key Features: *Unprecedented full regulatory findings on all registered triptan prescription medicines currently available in Japan; *Key package insert information and formulation specification and precise drawn-to-scale graphical representation of the 7 products for quick referencing; *Expert generated statistical and graphical findings for convenient regulatory and strategic research use; *Tabulated easy-to-find alphabetical listing previously unavailable in English. <<>> Analysis Highlights: All seven formulations of the four triptan products registered in Japan by January 2004 are listed. Included are a comprehensive profile of each product's approval and market entry timeline, as well as relevant medical, regulatory, formulation and therapeutic remarks on the product. The formulations are grouped by brand and the year of approval, starting with the first approved product under the Imigran brand. <<>> Practical Use to the Reader: *To champion opportunities in the Triptan market, strengthen internal positioning of headache pipeline portfolio, and identify lucrative licensing and co-marketing opportunities - this report is a must for product managers wanting to enter the Japanese market; *Regulatory affairs personnel seeking regulatory approval for their CNS product in Japan - an indispensable information source particularly for benchmarking their own product with the Japanese market in terms of approval timeline and registration feasibility; *Triptan marketing specialists can evaluate (or reevaluate) their Japan strategy by having access to regulatory information normally unavailable elsewhere; *Invaluable reference material to confirm or refute current concerns arising from your organization's regulatory strategy to register a triptan generic in Japan. <<>> For further inquieries, please send email to orders@jouhoukoukai.com <<>> Copyright JKS LLC 2004.

Related Item(s)
Code Name Price    
AJ_T_001All in Japan: Triptans (Single User License) $425.00
AJ_T_003All in Japan: Statins (Single User License) $3,450.00
AJ_T_004All in Japan: Statins (Enterprise-wide Use License) $7,500.00
AJ_T_005All in Japan: Anti-cancers (Single User License) $1,250.00
AJ_T_006All in Japan: Anti-cancers (Enterprise-wide Use License) $4,250.00